Sanofis Dual-action Biotech Asthma Drug

Sanofis Dual-action Biotech Asthma Drug - Psychology, Special Needs, Health - Posted: 12th Nov, 2014 - 12:30am

Text RPG Play Text RPG ?
 

Posts: 1 - Views: 324
Biotechnology News
Post Date: 12th Nov, 2014 - 12:30am / Post ID: #

Sanofis Dual-action Biotech Asthma Drug

Sanofis Dual-action Biotech Asthma Drug Performs Well In Test
Biotechnology News

(Reuters) - An experimental biotech drug for moderate to severe asthma from France's Sanofi and its U.S. Partner Regeneron has produced good results in clinical tests, suggesting that its dual-action mechanism may be highly effective. The encouraging data allows the companies to begin final-stage Phase III asthma trials on the medicine, which is also being developed for atopic dermatitis and chronic sinusitis with nasal polyps. Dupilumab is one of the new medicines Sanofi is expected discuss at an investor day on Nov. ...

Source

Sponsored Links:

 
> TOPIC: Sanofis Dual-action Biotech Asthma Drug
 

▲ TOP


International Discussions Coded by: BGID®
ALL RIGHTS RESERVED Copyright © 1999-2024
Disclaimer Privacy Report Errors Credits
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in our Cookies used here: Privacy / Disclaimer,